Michelle Nelken

Clinical Operations

Michelle Nelken has over 15 years experience in the pharmaceutical and biotechnology industry focusing on management of early and late phase clinical studies in multiple therapeutic areas, with a strong focus on rare diseases.  During her career, Ms. Nelken’s contribution has help lead to the approval of Genzyme’s Myozyme® for treatment of Pompe disease, Genzyme’s… Read More »

Christine Burton

Clinical Operations

Chrissy Burton has been an RN for over 12 years currently specializing in critical care with extensive background in surgical, medical, cardiac and hospice.  She joined Alopexx Enterprises 2 years ago to assist with the oversight of the clinical studies and performs as CRA for current clinical trials.